NCT00874926View on ClinicalTrials.gov

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

CompletedOBSERVATIONAL

Enrollment

405

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2012

Study Completion Date

April 30, 2013

Conditions

Hemophilia A

Interventions

BIOLOGICAL

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Haemophilia A patients

Trial Locations (17)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT00874926 - EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS | Biotech Hunter | Biotech Hunter